ZECHENG ELECTRONICS
837821
HUAWEI DESIGN
833427
Shenzhen Bestek Technology
300822
Shanghai Kaytune Industrial
301001
Guangdong Dtech Technology
301377
CN Stock MarketDetailed Quotes
688553 Sichuan Huiyu Pharmaceutical
- 14.07
- -0.08-0.57%
Trading Jan 9 13:43 CST
5.96BMarket Cap21.42P/E (TTM)
14.35High14.02Low22.23KlotVolume14.15Open14.15Pre Close31.58MTurnover0.72%Turnover Ratio42.64P/E (Static)423.60MShares18.6452wk High1.54P/B4.36BFloat Cap9.2452wk Low16.98Limit Up309.53MShs Float41.93Historical High11.32Limit Down2.33%Amplitude9.24Historical Low0.21Dividend TTM14.20Avg Price9.13KlotAsk1.51%Div YieldTTM100Lot Size12.26KlotBid
Sichuan Huiyu Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 36.36%944.77M | 12.71%567.48M | 46.41%282.32M | -37.14%953.78M | -44.80%692.85M | -42.09%503.5M | -60.29%192.83M | -20.74%1.52B | -11.45%1.26B | -0.51%869.42M |
| Refunds of taxes and levies | 16.07%15.92M | -87.22%1.71M | -86.25%1.7M | -54.65%14.41M | -48.98%13.71M | 31.95%13.39M | 149,459.93%12.4M | -18.57%31.76M | 7.87%26.88M | --10.14M |
| Cash received relating to other operating activities | -8.90%77.61M | -41.42%35.61M | -33.83%21.35M | 17.60%114.57M | -37.64%85.19M | 31.63%60.78M | 103.10%32.26M | -13.57%97.43M | 196.01%136.61M | -14.71%46.18M |
| Adjustment items of operating cash inflws | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 31.14%1.04B | 4.70%604.8M | 28.59%305.38M | -34.24%1.08B | -44.19%791.75M | -37.60%577.67M | -52.64%237.49M | -20.30%1.65B | -4.70%1.42B | -0.25%925.75M |
| Goods services cash paid | 65.30%175.31M | 71.36%100.82M | 61.01%41.62M | -36.42%143.67M | -52.06%106.05M | -50.71%58.84M | -64.61%25.85M | -28.12%225.97M | 15.39%221.21M | -22.65%119.37M |
| Staff behalf paid | -5.56%190.6M | -4.75%134.56M | -14.39%78.05M | 4.68%276.94M | 1.17%201.82M | 4.70%141.28M | 18.00%91.16M | 31.73%264.56M | 44.29%199.48M | 52.81%134.94M |
| All taxes paid | 233.14%72.77M | 578.40%57.89M | 159.30%31.93M | -67.97%31.24M | -71.96%21.84M | -83.84%8.53M | -61.48%12.31M | -23.45%97.52M | -16.57%77.91M | -26.80%52.82M |
| Cash paid relating to other operating activities | -0.93%437.37M | -9.78%271.09M | -14.39%140.34M | -34.76%563.98M | -34.92%441.48M | -36.80%300.47M | -25.98%163.94M | -11.53%864.48M | -4.81%678.35M | 19.03%475.38M |
| Cash outflows from operating activities | 13.59%876.05M | 10.85%564.35M | -0.45%291.94M | -30.06%1.02B | -34.47%771.2M | -34.94%509.11M | -27.36%293.26M | -10.32%1.45B | 3.61%1.18B | 9.57%782.51M |
| Net cash flows from operating activities | 689.45%162.24M | -41.00%40.45M | 124.09%13.44M | -65.51%66.93M | -91.50%20.55M | -52.14%68.56M | -157.09%-55.77M | -56.52%194.06M | -31.45%241.74M | -33.03%143.24M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -61.12%1.18B | -61.88%931M | -71.38%418M | -20.88%4.12B | -21.74%3.04B | -4.75%2.44B | 29.59%1.46B | 21.48%5.21B | -1.46%3.88B | 1.19%2.56B |
| Cash received from returns on investments | -15.83%17.16M | -23.55%10.39M | -69.11%2.35M | -24.64%35.86M | -37.31%20.39M | -31.23%13.59M | 5.34%7.61M | 302.22%47.58M | 191.64%32.53M | 231.82%19.77M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,613.98%85.8K | 83.46%5.8K | ---- | --39.2K | -53.99%3.16K | 187.40%3.16K | 126.49%2.49K | ---- | 7,620.00%6.87K | --1.1K |
| Cash inflows from investing activities | -60.81%1.2B | -61.67%941.4M | -71.37%420.35M | -20.91%4.16B | -21.87%3.06B | -4.95%2.46B | 29.43%1.47B | 22.25%5.26B | -0.91%3.91B | 1.73%2.58B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -54.82%110.8M | -54.10%84.13M | -35.77%60.67M | -35.72%296.72M | -27.27%245.21M | -15.20%183.31M | 46.73%94.46M | 6.50%461.61M | 2.74%337.17M | 10.94%216.15M |
| Cash paid to acquire investments | -61.89%953.04M | -65.77%673.04M | -76.92%320.1M | -27.03%3.63B | -27.97%2.5B | -18.93%1.97B | 17.34%1.39B | -13.36%4.97B | -10.59%3.47B | -11.60%2.43B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5M | ---- | ---- |
| Cash outflows from investing activities | -61.26%1.06B | -64.77%757.17M | -74.30%380.77M | -27.83%3.93B | -27.91%2.75B | -18.63%2.15B | 18.86%1.48B | -11.89%5.44B | -9.55%3.81B | -10.11%2.64B |
| Net cash flows from investing activities | -56.87%134.42M | -39.94%184.23M | 395.18%39.58M | 228.90%233.35M | 198.30%311.62M | 634.10%306.73M | 88.04%-13.41M | 90.33%-181.03M | 139.94%104.47M | 85.58%-57.43M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --1M | --1M | --1M | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 0.92%385M | 201.31%345M | 92.14%220M | 584.37%307.97M | 747.78%381.5M | 154.44%114.5M | --114.5M | 198.93%45M | 2,150.00%45M | 2,150.00%45M |
| Cash received relating to other financing activities | --212.83M | --98.43M | --48.78M | 1,321.49%176.94M | ---- | ---- | ---- | 1,031.56%12.45M | 1,073.60%12.91M | 1,073.60%12.91M |
| Cash inflows from financing activities | 56.30%597.83M | 283.92%443.43M | 134.74%268.78M | 745.83%485.9M | 560.51%382.5M | 99.45%115.5M | --114.5M | -97.60%57.45M | 1,768.05%57.91M | 1,768.05%57.91M |
| Borrowing repayment | 415.41%231.93M | 347.78%201.5M | --54.5M | 252.08%46.47M | -29.04%45M | -29.04%45M | ---- | 1,219.82%13.2M | 6,241.85%63.42M | 6,241.85%63.42M |
| Dividend interest payment | -6.07%94.92M | -8.40%92.19M | 650.29%2.4M | 8.83%98.12M | 9.88%101.05M | 58,889.57%100.64M | 96.54%319.47K | 12,961.48%90.16M | 17,590.30%91.96M | -46.97%170.61K |
| Cash payments relating to other financing activities | --237.87M | --122.87M | --80M | 304.99%219.02M | ---- | ---- | ---- | 33.62%54.08M | ---- | ---- |
| Cash outflows from financing activities | 286.66%564.73M | 186.02%416.56M | 42,751.80%136.9M | 130.95%363.61M | -6.00%146.05M | 129.04%145.64M | -99.36%319.47K | 273.40%157.44M | 5,830.98%155.38M | 2,525.78%63.59M |
| Net cash flows from financing activities | -86.00%33.11M | 189.12%26.86M | 15.51%131.88M | 222.31%122.3M | 342.57%236.45M | -430.74%-30.14M | 327.62%114.18M | -104.26%-99.99M | -20,401.12%-97.47M | -937.34%-5.68M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | 1,119.53%1.64M | ---- | ---- | ---- | -283.04%-160.95K | ---- | ---- |
| Net increase in cash and cash equivalents | -42.01%329.77M | -27.12%251.54M | 310.90%184.9M | 586.91%424.22M | 128.60%568.62M | 330.73%345.14M | 169.63%45M | -109.46%-87.12M | 171.80%248.73M | 143.60%80.13M |
| Add:Begin period cash and cash equivalents | 35.18%1.63B | 35.18%1.63B | 35.18%1.63B | -6.74%1.21B | -6.74%1.21B | -6.74%1.21B | -7.66%1.21B | 248.02%1.29B | 248.02%1.29B | 248.02%1.29B |
| Adjustment items for cash and cash equivalent increase | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
| End period cash equivalent | 10.45%1.96B | 21.32%1.88B | 45.10%1.81B | 35.18%1.63B | 15.10%1.77B | 12.96%1.55B | 0.77%1.25B | -6.74%1.21B | 232.96%1.54B | 631.41%1.37B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
